PL3606929T3 - Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania - Google Patents

Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania

Info

Publication number
PL3606929T3
PL3606929T3 PL18781797T PL18781797T PL3606929T3 PL 3606929 T3 PL3606929 T3 PL 3606929T3 PL 18781797 T PL18781797 T PL 18781797T PL 18781797 T PL18781797 T PL 18781797T PL 3606929 T3 PL3606929 T3 PL 3606929T3
Authority
PL
Poland
Prior art keywords
beta
preparation
methods
nicotinate ester
nucleotides
Prior art date
Application number
PL18781797T
Other languages
English (en)
Inventor
Anthony A. Sauve
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Publication of PL3606929T3 publication Critical patent/PL3606929T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/02Phosphorylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048Pyridine radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL18781797T 2017-04-05 2018-04-05 Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania PL3606929T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762481912P 2017-04-05 2017-04-05
PCT/US2018/026209 WO2018187540A1 (en) 2017-04-05 2018-04-05 Beta-nicotinate ester nucleotides and processes for preparing same
EP18781797.8A EP3606929B1 (en) 2017-04-05 2018-04-05 Beta-nicotinate ester nucleotides and processes for preparing same

Publications (1)

Publication Number Publication Date
PL3606929T3 true PL3606929T3 (pl) 2021-12-27

Family

ID=63712318

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18781797T PL3606929T3 (pl) 2017-04-05 2018-04-05 Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania

Country Status (19)

Country Link
US (2) US10961268B2 (pl)
EP (1) EP3606929B1 (pl)
JP (1) JP7182289B2 (pl)
KR (1) KR102605369B1 (pl)
CN (1) CN110709406B (pl)
AU (2) AU2018250242B2 (pl)
CA (1) CA3059228C (pl)
CY (1) CY1124450T1 (pl)
DK (1) DK3606929T3 (pl)
ES (1) ES2887224T3 (pl)
HR (1) HRP20211296T1 (pl)
HU (1) HUE055521T2 (pl)
LT (1) LT3606929T (pl)
PL (1) PL3606929T3 (pl)
PT (1) PT3606929T (pl)
RS (1) RS62284B1 (pl)
SI (1) SI3606929T1 (pl)
SM (1) SMT202100496T1 (pl)
WO (1) WO2018187540A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101360421B (zh) 2005-11-18 2014-06-18 康乃尔研究基金会有限公司 烟酰核苷组合物及其使用方法
JP6949002B6 (ja) 2015-08-05 2021-11-17 メトロ インターナショナル バイオテック,エルエルシー ニコチンアミドモノヌクレオチド誘導体及びそれらの使用
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
AU2018250242B2 (en) 2017-04-05 2021-07-15 Cornell University Beta-nicotinate ester nucleotides and processes for preparing same
US20210388018A1 (en) * 2018-10-01 2021-12-16 Cornell University Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
WO2022251491A1 (en) * 2021-05-27 2022-12-01 Metro International Biotech, Llc Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
CN113527376A (zh) * 2021-08-06 2021-10-22 上海昶法新材料有限公司 β-烟酰胺单核苷酸的制备方法
CA3241560A1 (en) * 2021-12-22 2023-06-29 James M. Mckearin Compositions for treatment of inflammation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736314A (en) * 1967-06-02 1973-05-29 Syntex Corp Unsaturated nucleoside phosphonates phosphonic acids and phosphonic acid salts
CN101360421B (zh) 2005-11-18 2014-06-18 康乃尔研究基金会有限公司 烟酰核苷组合物及其使用方法
US9790252B2 (en) 2009-07-01 2017-10-17 Cornell University 2-fluorinated riboses and arabinoses and methods of use and synthesis
US9603862B2 (en) 2009-12-14 2017-03-28 Cornell University Activation and activators of SIRT5
WO2011081945A2 (en) 2009-12-14 2011-07-07 Cornell University Activation and activators of sirt6
WO2011146636A2 (en) 2010-05-18 2011-11-24 Cornell University Reagents and methods for sirtuin capture
EP2872128B1 (en) 2012-07-16 2020-02-19 Cornell University Nicotinamide riboside to treat hearing loss
CA2951287A1 (en) * 2014-06-06 2015-12-10 Glaxosmithkline Intellectual Property (No. 2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
US20160035539A1 (en) 2014-07-30 2016-02-04 Lauri SAINIEMI Microfabrication
US10525070B2 (en) 2015-02-10 2020-01-07 Duke University Method of treating heart failure
EP3274357B1 (en) 2015-03-27 2019-12-11 Cornell University Efficient synthesis of nicotinamide mononucleotide
US20160355539A1 (en) * 2015-06-04 2016-12-08 Chromadex, Inc. Selective solvent free phosphorylation
WO2017011788A1 (en) 2015-07-15 2017-01-19 Cornell University Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
AU2018250242B2 (en) 2017-04-05 2021-07-15 Cornell University Beta-nicotinate ester nucleotides and processes for preparing same
US20210388018A1 (en) 2018-10-01 2021-12-16 Cornell University Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof

Also Published As

Publication number Publication date
SI3606929T1 (sl) 2021-11-30
AU2018250242B2 (en) 2021-07-15
ES2887224T3 (es) 2021-12-22
LT3606929T (lt) 2021-10-25
SMT202100496T1 (it) 2021-11-12
KR20190137133A (ko) 2019-12-10
AU2021250984A1 (en) 2021-11-18
CN110709406A (zh) 2020-01-17
US10961268B2 (en) 2021-03-30
WO2018187540A1 (en) 2018-10-11
US20210214386A1 (en) 2021-07-15
HUE055521T2 (hu) 2021-11-29
AU2021250984B2 (en) 2022-09-01
JP2020516619A (ja) 2020-06-11
HRP20211296T1 (hr) 2021-11-12
CA3059228C (en) 2025-03-18
EP3606929A4 (en) 2020-05-06
KR102605369B1 (ko) 2023-11-24
JP7182289B2 (ja) 2022-12-02
CA3059228A1 (en) 2018-10-11
DK3606929T3 (da) 2021-08-23
AU2018250242A1 (en) 2019-10-31
EP3606929A1 (en) 2020-02-12
CN110709406B (zh) 2022-11-08
RS62284B1 (sr) 2021-09-30
PT3606929T (pt) 2021-09-02
US20200031860A1 (en) 2020-01-30
US11530233B2 (en) 2022-12-20
CY1124450T1 (el) 2022-07-22
EP3606929B1 (en) 2021-06-02

Similar Documents

Publication Publication Date Title
PL3606929T3 (pl) Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania
IL271025A (en) Multibiotic agents and methods of using the same
IL293377B1 (en) Hsd17b13 variants and uses thereof
PL3601358T3 (pl) Przeciwciała anty-trem2 i sposoby ich wykorzystania
IL282048A (en) Oxysterols and methods of use thereof
PL3250610T3 (pl) Przeciwciała anty-FcRn i sposoby ich stosowania
IL269334A (en) Improved t cell compositions and methods
IL259747A (en) Antibodies targeting fc receptor-like 5 and methods of use
IL255269A (en) Compositions of obeticholic acid and methods of use
PL3828194T3 (pl) Oksysterole i sposoby ich stosowania
IL257203B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
PL3183260T3 (pl) Modyfikowane oligonukleotydy i sposoby ich syntezy
PL3353210T3 (pl) Przeciwciała anty-TIGIT i sposoby stosowania
PL3215532T3 (pl) Przeciwciała anty-TIM3 i sposoby ich zastosowania
CL2018000708A1 (es) Fitasas modificadas y métodos de uso
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
PL3394259T3 (pl) Kompozycje i sposoby zmniejszania ekspresji tau
PT3325669T (pt) Composições e métodos de análise de rna
HUE046756T2 (hu) Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei
HUE061084T2 (hu) PVRIG elleni antitestek és alkalmazási eljárások
PL3212225T3 (pl) Sposoby i kompozycje zmodyfikowanych limfocytów t
IL256322B (en) Improved formulations of deferasirox and methods of making the same
IL254670A0 (en) Humanized anti-c1s antibodies and methods of use thereof
PL3389636T3 (pl) Kompozycje i metody wytwarzania mikrocząstek białkowych
JP2018172409A5 (ja) 15−hepeを含む組成物および同組成物を使用する方法